Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-03 Conversion | 2025-02-04 5:31 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC 10% Owner | 71,439,297 | $0 | 7,024,758 (Direct) | View |
| 2024-12-09 Disposition | 2025-02-04 4:37 pm | N/A 2033-03-08 | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 5,704 | $0 | 343,490 (Direct) | View |
| 2025-02-03 Conversion | 2025-02-04 4:37 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 2,903,040 | $0 | 343,490 (Indirect) | View |
| 2024-12-09 Option Award | 2025-02-04 4:37 pm | N/A 2033-03-08 | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 14,790 | $0 | 343,490 (Direct) | View |
| 2024-12-09 Disposition | 2025-02-04 4:35 pm | N/A 2031-03-03 | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 132,764 | $0 | 251,293 (Direct) | View |
| 2025-02-03 Conversion | 2025-02-04 4:35 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 422,206 | $0 | 251,293 (Direct) | View |
| 2024-11-26 Conversion | 2025-02-04 4:35 pm | N/A 2026-12-15 | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 75,000 | $78,962 | 251,293 (Indirect) | View |
| 2024-12-09 Option Award | 2025-02-04 4:35 pm | N/A 2031-03-03 | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 178,402 | $0 | 251,293 (Direct) | View |
Ownership | 2025-01-30 8:55 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC 10% Owner | 0 | $0 | 65,036,879 (Direct) | View |
Ownership | 2025-01-30 4:42 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 37,588,634 (Indirect) | View |
Ownership | 2025-01-30 4:38 pm | N/A 2030-10-25 | Maze Therapeutics Inc. | MAZE | SPIEGELMAN DANIEL K Director | 0 | $0 | 35,534 (Direct) | View |
Ownership | 2025-01-30 4:37 pm | N/A 2031-02-01 | Maze Therapeutics Inc. | MAZE | Sohn Catherine A. Director | 0 | $0 | 35,534 (Direct) | View |
Ownership | 2025-01-30 4:35 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | SCHELLER RICHARD H Director | 0 | $0 | 43,643 (Direct) | View |
Ownership | 2025-01-30 4:34 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 0 | $0 | 2,630,618 (Direct) | View |
Ownership | 2025-01-30 4:33 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Kathiresan Sekar Director | 0 | $0 | 133,553 (Direct) | View |
Ownership | 2025-01-30 4:31 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 0 | $0 | 520,621 (Direct) | View |
Ownership | 2025-01-30 4:27 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Brush James Director | 0 | $0 | 15,731,923 (Indirect) | View |
Ownership | 2025-01-30 4:25 pm | N/A 2031-02-01 | Maze Therapeutics Inc. | MAZE | Andrews Nancy C Director | 0 | $0 | 35,534 (Direct) | View |
Ownership | 2025-01-30 4:24 pm | N/A 2034-07-17 | Maze Therapeutics Inc. | MAZE | Courtney Phillips GC and Corp. Secretary | 0 | $0 | 139,403 (Direct) | View |
Ownership | 2025-01-30 4:22 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 0 | $0 | 555,438 (Direct) | View |
Ownership | 2025-01-30 4:21 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 0 | $0 | 123,874 (Direct) | View |
Ownership | 2025-01-30 4:19 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 0 | $0 | 327,556 (Direct) | View |
Ownership | 2025-01-30 4:17 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 0 | $0 | 1,881,803 (Direct) | View |